Anti-Her3 scFV fragment and bispecific anti-c-Met/anti-Her3 antibodies comprising the same
US9505843B2 · kind B2 · utility
16Cited by
7References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2014 |
| Grant date | Nov 29, 2016 |
| Priority date | — |
| Expiry date | Nov 21, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is an anti-Her3 antibody or antigen-binding fragment thereof, an anti-c-Met/anti-Her3 bispecific antibody including the same, and a method of preventing and/or treating a cancer using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.